
Pharmalittle: We’re reading about J&J building U.S. plants, a weight loss-drug race in India, and more
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal
Jennifer Weinberg, MD, Physician Advisor and Vice President of Operations, R1 While artificial intelligence (AI) can automate many functions within the middle revenue cycle, there
A quarter-century ago, the United States celebrated a victory over measles, a highly contagious illness that once infected millions of American children each year. In
In the run-up to President Trump’s reelection last November, Texas and 16 other states filed a lawsuit that disability advocates now say could upend one
Egg prices have risen 50% since March 2024, the result of an ongoing bird flu crisis that has both producers and consumers grappling for solutions.
NEW YORK — For decades, Bill Nye the Science Guy has imparted a simple message to generations of kids and adults: “Science rules!” The catchphrase
Do scientists put themselves at risk by speaking out against the Trump administration? “Hell yes,” said Jonathan Jackson, a national expert on increasing diversity in
What You Should Know: A silent crisis is unfolding across the United States, as pharmacy deserts proliferate, leaving millions of Americans without convenient access to
EQS-News: Douglas AG / Key word(s): Profit Warning/Change in Forecast Weakening customer sentiment and slower market development: DOUGLAS Group adjusts 2024/25 guidance 20.03.2025 / 19:40
Douglas AG / Key word(s): Profit Warning/Change in Forecast Douglas AG: Weakening customer sentiment and slower market development: DOUGLAS AG adjusts 2024/25 forecast 20-March-2025 /